News
Also: Pear Therapeutics receives FDA SteP designation for its product candidate focused on acute and chronic pain, and Carbon Health launches its diabetes management program.
The company said it's currently focused on managing end-stage kidney disease, but it's investigating using the system for other clinical areas.
The service gives clinicians with OUD access to virtual care.
Its exoskeleton robots have been used in over 200 hospitals in China to help patients walk again.
The digital platform enables clinicians to adjust their patient's devices remotely and in real-time.
The study did not find find a significant difference in depression symptoms between the intervention and control group.
The startup said the round brings its total raise to $17.5 million.
The company now operates in six states and treats mental health conditions and substance use disorder.
A study published in The Lancet found a deep learning model trained to detect a certain type of hip fractures outperformed radiologists, but further testing found potential barriers to safe use.
His appointment comes ahead of the med tech startup's clinical trials for its continuous molecular monitoring device.